anmelden
OMX Nordic 40
2.603,85
PKT
-30,09
PKT
-1,14
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 05.04.19 | AstraZeneca buy | Deutsche Bank AG | |
| 03.04.19 | AstraZeneca buy | Kepler Cheuvreux | |
| 03.04.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 03.04.19 | Volvo (B) Underperform | Merrill Lynch & Co., Inc. | |
| 03.04.19 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | Credit Suisse Group | |
| 03.04.19 | A.P. Moeller - Maersk A-S (B) buy | HSBC | |
| 02.04.19 | Volvo (B) buy | Goldman Sachs Group Inc. | |
| 02.04.19 | Hennes Mauritz (H M, H&M) Underperform | Credit Suisse Group | |
| 02.04.19 | AstraZeneca Sell | UBS AG | |
| 02.04.19 | AstraZeneca Reduce | HSBC | |
| 01.04.19 | AstraZeneca overweight | Barclays Capital | |
| 01.04.19 | AstraZeneca Neutral | UBS AG | |
| 01.04.19 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 01.04.19 | AstraZeneca buy | Deutsche Bank AG | |
| 01.04.19 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 30.03.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 29.03.19 | AstraZeneca overweight | Barclays Capital | |
| 29.03.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.03.19 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 26.03.19 | Volvo (B) buy | HSBC | |
| 22.03.19 | Nokia buy | UBS AG | |
| 21.03.19 | Nokia Outperform | Credit Suisse Group | |
| 20.03.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 19.03.19 | ABB (Asea Brown Boveri) Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.03.19 | ABB (Asea Brown Boveri) buy | HSBC | |
| 18.03.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 12.03.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 11.03.19 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | UBS AG | |
| 05.03.19 | Novo Nordisk Outperform | Bernstein Research | |
| 05.03.19 | AstraZeneca buy | Deutsche Bank AG | |
| 05.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.03.19 | Novo Nordisk Reduce | HSBC | |
| 04.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.03.19 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 04.03.19 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 04.03.19 | Ericsson (Telefon L.M.Ericsson) (B) buy | Goldman Sachs Group Inc. | |
| 01.03.19 | Nokia buy | Kepler Cheuvreux | |
| 01.03.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 28.02.19 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets |